Loading...
XSAU
2230
Market cap1.75bUSD
Nov 12, Last price  
7.77SAR
Name

Saudi Chemical Holding Company SJSC

Chart & Performance

D1W1MN
XSAU:2230 chart
P/E
19.54
P/S
0.95
EPS
0.40
Div Yield, %
0.64%
Shrs. gr., 5y
-0.12%
Rev. gr., 5y
15.79%
Revenues
6.88b
+7.93%
1,230,134,0001,537,157,0001,643,337,0001,687,342,0001,867,573,0002,001,333,0002,275,121,0002,484,315,0002,409,773,0002,146,031,0002,481,569,0002,948,532,0002,949,168,0003,306,160,0003,410,980,0003,695,868,0004,854,848,0006,375,284,0006,880,700,000
Net income
335m
+15.13%
111,776,000200,534,000301,019,000303,171,000267,404,000291,279,000300,603,000283,561,000251,631,000137,816,000143,098,000115,993,00032,877,00074,026,00069,570,00080,223,000182,886,000291,241,000335,300,000
CFO
491m
P
95,554,000215,878,000407,385,000151,286,000131,333,000205,400,000111,366,000315,366,000-189,024,000-4,746,000143,490,000-71,358,000-54,496,00043,224,00023,135,000715,809,000433,023,000-260,150,000490,659,000
Dividend
May 25, 20250.05 SAR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Saudi Chemical Holding Company is a diversified enterprise with operations in explosives, pharmaceuticals, and the production of ammonium nitrate, serving markets within Saudi Arabia and globally. The company manufactures and sells explosive materials and their derivatives for both civil and military purposes, complemented by specialized technical support services for explosive operations. Furthermore, it is deeply involved in the medical sector, encompassing the manufacturing, wholesale distribution, and retail of a broad array of products. This includes medicines, medical materials, syrups, pharmaceutical preparations, medical and surgical instruments, supplies for hospitals and healthcare centers, associated spare parts, and food items. Another core industrial activity is the production of ammonium nitrate. Established in 1972, Saudi Chemical Holding Company's headquarters are located in Riyadh, Saudi Arabia.
IPO date
May 06, 2001
Employees
Domiciled in
SA
Incorporated in
SA

Valuation

Title
SAR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT